Canada’s leading public companies and investment dealers regularly turn to us to handle their corporate finance transactions and securities regulatory matters, tapping into our national and international presence to access our exceptional cross-border capability in principal markets. We have extensive experience with public offerings, including initial public offerings, acquisition finance and innovative fund structures, as well as private placements. We routinely advise corporations, trusts and investment banks on all types of securities regulatory matters and have unsurpassed knowledge of securities regulation gained, in part, through our work with Canadian securities regulators. We also have specialized experience advising on environmental, social and governance (ESG) issues in connection with corporate financing, fund structuring, investment transactions, ESG reporting and disclosure obligations. To view a list of our most recent representative matters, please visit Equity Capital Markets , or Debt Capital Markets.
In 2021, Blakes was the top firm in Canada, according to rankings from Bloomberg, Financial Post and Refinitiv. A selection of our rankings is below:
No. 1 in Canadian equity and debt financings, for issuers and underwriters combined, by deal count (Bloomberg, Financial Post, Refinitiv)
No. 1 Canadian firm in global equity and equity linked offerings, for issuers and underwriters combined, by deal value (Bloomberg)
No. 1 Canadian firm in global equity and equity linked offerings, for issuers, by deal count (Bloomberg)
No. 1 Canadian firm in global corporate bonds, for issuers, by deal value (Bloomberg)
No. 1 in Canadian equity IPOs, for issuers and underwriters combined, by deal count and deal value (Bloomberg)
No. 1 in Canadian equity, equity linked and preferred offerings, for issuers and underwriters combined, by deal count and deal value (Bloomberg)
No. 1 in Canadian equity offerings, for issuers and underwriters combined, by deal count and deal value (Financial Post)
No. 1 Canadian firm for global green bonds, for issuers, by deal value (Bloomberg)
No. 1 in Canadian technology deals, for issuers, by deal count (Bloomberg)
No. 1 in Canadian health care deals, for issuers, by deal count (Bloomberg)